Current share price of US$483 suggests Vertex Pharmaceuticals is potentially 44% undervalued Analyst price target for VRTX is US$509 which is 40% below our fair value estimate ...
A lot of economists and grocery price watchdogs think that unit pricing — presented along with the shelf price — is one way to overcome this confusion and to protect yourself from “shrinkflation,” a ...